LENAPHARM
ActiveActs, filings and financial milestones
2026
21-04
Gazette deed
Legal-form change · Resignations & appointmentsLegal-form conversion · Capital conversion · Reserve release5 points ▸
Gazette deed
Legal-form change · Resignations & appointments
Legal-form conversion · Capital conversion · Reserve release5 points ▸
- General meeting, 09-04-2026
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Reserve release, “suppression compte capitaux propres statutairement indisponible”, 20460 (deed in French)
- Amendment of the articles, “10 à 12” (deed in French)
2025
18-10
micro format · 79 days late
2024
15-10
micro format · 76 days late
2023
17-10
micro format · 78 days late
2022
31-12
Financial
Equity above €100,000equity €107,203 ▲24.5%
After 2 profitable years in a row, equity reaches €107,203.
12-12
micro format · 134 days late
09-12
Gazette deed
Transfer of 25 sharesAppointment: Hamed Mohamad (director) · Shareholding8 points ▸
Gazette deed
Transfer of 25 shares
Appointment: Hamed Mohamad (director) · Shareholding8 points ▸
- General meeting, 02-01-2018
- Share transfer, Badreddine Fayza → Hamed Mohamad
- Badreddine Fayza holds 25 shares
- Hamed Mohamad holds 25 shares
- Macki Anwar holds 50 shares
- Capital
- General meeting, 01-10-2022
- Director appointment, Hamed Mohamad (director)
24-01
micro format · 177 days late
2021
31-12
Financial
Back to profitnet €4,460
The net result is €4,460, after one loss-making year.
12-08
full format · 377 days late
2020
31-12
Financial
Weakest financial yearnet -€18,023
The net result drops to -€18,023, the lowest from 2018 to 2024. It recovers the following year.
2019
31-08
micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank